New TB Vaccines, an Experimental Nasal Shot, and Phase-3 Results: The Race to Replace BCG
On April 10, 2026, the British Medical Journal published results from the PreVenTB trial — a randomised, Phase-3 clinical trial conducted in India. The final stage of human testing before a vaccine can be considered for regulatory approval
